Metraipolis › archive › dc_26727285607d

Pharmacokinetics and nephrotoxicity of cisplatin modulated by combination therapy with brusatol — Europe PMC PMID:41737553

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41737553
DOI
10.3389/fphar.2026.1708101
License (as archived)
solo-consultazione
Archived
2026-11-06T00:14:28.533Z
SHA-256 of the archived text
06a6a51ea5392fbc58097bb634ecd8375df834261ed811720a01819920f0dd51
Stable URL of this page
https://metraipolis.com/documento/dc_26727285607d

How to cite

Pharmacokinetics and nephrotoxicity of cisplatin modulated by combination therapy with brusatol — Europe PMC PMID:41737553 — Europe PMC (en), https://europepmc.org/article/MED/41737553 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_26727285607d (Metraipolis archive dc_26727285607d, sha256 06a6a51ea5392fbc58097bb634ecd8375df834261ed811720a01819920f0dd51)
BibTeX
@misc{dc26727285607d,
  title = {Pharmacokinetics and nephrotoxicity of cisplatin modulated by combination therapy with brusatol — Europe PMC PMID:41737553},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41737553},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_26727285607d; sha256 06a6a51ea5392fbc58097bb634ecd8375df834261ed811720a01819920f0dd51},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41737553. Agents can read the archived copy with the MCP tool read_document.